Does zearalenone have estrogen-like activity?

Zearalenone (ZEN) is a non-steroidal mycotoxin produced by Fusarium species that acts as a potent xenoestrogen, mimicking endogenous estrogenic activity. Its capacity to alter endocrine homeostasis is highly relevant for hormone-sensitive physiology.

Receptor-level affinity and dynamics

• Direct receptor binding: ZEN directly binds to human estrogen receptors ERα and ERβ, competing with endogenous 17β-estradiol.
• Binding kinetics: ZEN exhibits moderate-affinity binding with half-maximal inhibitory concentration ($\text{IC}_{50}$) values of approximately 240 nM for ERα and 166 nM for ERβ, translating to a relative binding affinity of roughly 7.5% to 11% of 17β-estradiol.

Downstream signaling and metabolic amplification

• Pathway activation: Upon binding, ZEN alters estrogen-responsive gene transcription. It acts as a full agonist at ERα to drive downstream gene expression, while functioning as a mixed agonist-antagonist at ERβ.
• Metabolic enhancement: Once ingested, ZEN is metabolized into $\alpha$-zearalenol (alpha-zearalenol). This primary metabolite exhibits substantially higher relative binding affinity and agonist potency at estrogen receptors than the parent compound.
• Multi-receptor disruption: Beyond estrogenic pathways, ZEN and its metabolites act as antagonists at the androgen receptor, contributing to wider endocrine disruption.

Bottom line

• Zearalenone is a highly active xenoestrogen that directly binds human ERα and ERβ, alters downstream gene transcription, and undergoes metabolic conversion to the even more potent $\alpha$-zearalenol, driving significant endocrine-disrupting activity.